Preparation and evaluation of ziprasidone–phospholipid complex from sustained‐release pellet formulation with enhanced bioavailability and no food effect
ConclusionsThe results indicated a sustained release with prolonged actions of schizophrenia and bipolar disorder treatment.
Source: Journal of Pharmacy and Pharmacology - Category: Drugs & Pharmacology Authors: Yanfei Miao, Guoguang Chen, Lili Ren, Pingkai Ouyang Tags: Research Paper Source Type: research
More News: Bipolar | Drugs & Pharmacology | Geodon | Mania | PET Scan | Schizophrenia | Study | Ziprasidone